[35] In 2019 a larger single center, randomized, controlled trial demonstrates that a combined administration of intravenous iron, EPO, B12 vitamin and folic acid on the day before cardiac surgery, significantly reduced the risk of RBC transfusion in patients with overt preoperative anemia or isolated iron deficiency. Here, EPO is linked to anemia.